CYRAMZA
CYRAMZA
Approved
DIN Number
02443805
Drug Class
Human
Market Date
Sep 10, 2015
Company
HC
eli lilly canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02443805
AIG Number0157132001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01FG02 RAMUCIRUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
RAMUCIRUMABActive
Strength: 10 MG / ML
Monograph: RAMUCIRUMAB